These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17261772)

  • 1. Hormonal treatment of human hepatocellular carcinoma.
    Di Maio M; De Maio E; Morabito A; D'Aniello R; De Feo G; Gallo C; Perrone F
    Ann N Y Acad Sci; 2006 Nov; 1089():252-61. PubMed ID: 17261772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is human hepatocellular carcinoma a hormone-responsive tumor?
    Di Maio M; Daniele B; Pignata S; Gallo C; De Maio E; Morabito A; Piccirillo MC; Perrone F
    World J Gastroenterol; 2008 Mar; 14(11):1682-9. PubMed ID: 18350599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Does anti-estrogen therapy after estrogen receptor analysis have value in palliative therapy of hepatocellular carcinoma?].
    Kreysel C; Porschen R
    Z Gastroenterol; 1998 Jul; 36(7):605-7. PubMed ID: 9738309
    [No Abstract]   [Full Text] [Related]  

  • 4. Type of estrogen receptor determines response to antiestrogen therapy.
    Villa E; Dugani A; Fantoni E; Camellini L; Buttafoco P; Grottola A; Pompei G; De Santis M; Ferrari A; Manenti F
    Cancer Res; 1996 Sep; 56(17):3883-5. PubMed ID: 8752151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.
    Chow PK; Tai BC; Tan CK; Machin D; Win KM; Johnson PJ; Soo KC;
    Hepatology; 2002 Nov; 36(5):1221-6. PubMed ID: 12395333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen for hepatocellular carcinoma.
    Nowak A; Findlay M; Culjak G; Stockler M
    Cochrane Database Syst Rev; 2004; (3):CD001024. PubMed ID: 15266436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of tamoxifen in hepatocellular carcinoma: a review and paradigm shift.
    Tan CK; Chow PK; Findlay M; Wong C; Machin D
    J Gastroenterol Hepatol; 2000 Jul; 15(7):725-9. PubMed ID: 10937676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen in hepatocellular carcinoma.
    Chow P; Kiat TC; Choo TB; Machin D
    Lancet; 1998 Sep; 352(9130):819-20. PubMed ID: 9737316
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.
    Nowak AK; Stockler MR; Chow PK; Findlay M
    Cancer; 2005 Apr; 103(7):1408-14. PubMed ID: 15744746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study.
    Liu CL; Fan ST; Ng IO; Lo CM; Poon RT; Wong J
    Am J Gastroenterol; 2000 Jan; 95(1):218-22. PubMed ID: 10638587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen.
    Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
    Hepatology; 2004 Dec; 40(6):1361-9. PubMed ID: 15565568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors.
    Villa E; Ferretti I; Grottola A; Buttafoco P; Buono MG; Giannini F; Manno M; Bertani H; Dugani A; Manenti F
    Br J Cancer; 2001 Apr; 84(7):881-5. PubMed ID: 11286465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
    Barbare JC; Bouché O; Bonnetain F; Raoul JL; Rougier P; Abergel A; Boige V; Denis B; Blanchi A; Pariente A; Milan C; Bedenne L
    J Clin Oncol; 2005 Jul; 23(19):4338-46. PubMed ID: 15994145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma.
    Chow PK
    Cancer Treat Rev; 2005 Oct; 31(6):491-5. PubMed ID: 16214294
    [No Abstract]   [Full Text] [Related]  

  • 15. Octreotide therapy for hepatocellular carcinoma: a systematic review of the evidence from randomized controlled trials.
    Jia WD; Zhang CH; Xu GL; Ge YS; Wang W
    Hepatogastroenterology; 2010; 57(98):292-9. PubMed ID: 20583430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of estrogen receptors in hepatocellular carcinoma and its response to anti-estrogen therapy].
    Zheng T; Zhang Q; Xie Z
    Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):451-3. PubMed ID: 10920881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal treatment of hepatocellular carcinoma.
    Wilkinson ML; Forbes A
    J Hepatol; 1992 Mar; 14(2-3):406-7. PubMed ID: 1323605
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental studies on endocrine therapy for rat hepatocellular carcinoma].
    Zeze F; Onami S; Osato K
    Nihon Geka Gakkai Zasshi; 1995 Nov; 96(11):760-5. PubMed ID: 8569676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine treatment of hepatocellular carcinoma. Any evidence of benefit?
    Pignata S; Daniele B; Gallo C; De Vivo R; Monfardini S; Perrone F
    Eur J Cancer; 1998 Jan; 34(1):25-32. PubMed ID: 9624234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma.
    Gelmann EP
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-65-S1-70. PubMed ID: 9045318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.